328 related articles for article (PubMed ID: 26092099)
1. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Cardiovasc Res; 2015 Sep; 107(4):568-78. PubMed ID: 26092099
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Pharmacol Res; 2016 Nov; 113(Pt A):356-363. PubMed ID: 27633407
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation.
Wheal AJ; Cipriano M; Fowler CJ; Randall MD; O'Sullivan SE
J Pharmacol Exp Ther; 2014 Nov; 351(2):457-66. PubMed ID: 25212218
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
5. Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Sadowska O; Kozłowski M; Kusaczuk M; Kasacka I; Malinowska B
J Hypertens; 2020 May; 38(5):896-911. PubMed ID: 31800399
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
Sudhahar V; Shaw S; Imig JD
Eur J Pharmacol; 2009 Apr; 607(1-3):143-50. PubMed ID: 19326479
[TBL] [Abstract][Full Text] [Related]
7. ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK
López-Dyck E; Andrade-Urzúa F; Elizalde A; Ferrer-Villada T; Dagnino-Acosta A; Huerta M; Osuna-Calleros Z; Rangel-Sandoval C; Sánchez-Pastor E
Pharmacol Rep; 2017 Dec; 69(6):1131-1139. PubMed ID: 29128791
[TBL] [Abstract][Full Text] [Related]
8. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
Ho WS; Hiley CR
Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery.
Al Suleimani YM; Al Mahruqi AS; Hiley CR
Eur J Pharmacol; 2015 Oct; 765():107-14. PubMed ID: 26297305
[TBL] [Abstract][Full Text] [Related]
10. Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.
Lobato NS; Filgueira FP; Prakash R; Giachini FR; Ergul A; Carvalho MH; Webb RC; Tostes RC; Fortes ZB
PLoS One; 2013; 8(5):e63449. PubMed ID: 23667622
[TBL] [Abstract][Full Text] [Related]
11. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
[TBL] [Abstract][Full Text] [Related]
12. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles.
Su EN; Kelly ME; Cringle SJ; Yu DY
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4029-37. PubMed ID: 26098470
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current.
Begg M; Mo FM; Offertaler L; Bátkai S; Pacher P; Razdan RK; Lovinger DM; Kunos G
J Biol Chem; 2003 Nov; 278(46):46188-94. PubMed ID: 12952947
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery.
AlSuleimani YM; Hiley CR
Eur J Pharmacol; 2013 Feb; 702(1-3):1-11. PubMed ID: 23340219
[TBL] [Abstract][Full Text] [Related]
15. Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity.
Wheal AJ; Alexander SP; Randall MD
Br J Pharmacol; 2010 Jun; 160(3):701-11. PubMed ID: 20590573
[TBL] [Abstract][Full Text] [Related]
16. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
Hoi PM; Hiley CR
Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 pathway contributes to methanandamide-induced vasorelaxation in rat aorta.
López-Miranda V; Dannert MT; Herradón E; Alsasua A; Martín MI
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):379-89. PubMed ID: 20814734
[TBL] [Abstract][Full Text] [Related]
18. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
Mo FM; Offertáler L; Kunos G
Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151
[TBL] [Abstract][Full Text] [Related]
19. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent vascular actions of cannabidiol in the rat aorta.
O'Sullivan SE; Sun Y; Bennett AJ; Randall MD; Kendall DA
Eur J Pharmacol; 2009 Jun; 612(1-3):61-8. PubMed ID: 19285060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]